Cargando…

Cooperation in Countering Artemisinin Resistance in Africa: Learning from COVID-19

Detalles Bibliográficos
Autores principales:	Rosenthal, Philip J., Björkman, Anders, Dhorda, Mehul, Djimde, Abdoulaye, Dondorp, Arjen M., Gaye, Oumar, Guerin, Philippe J., Juma, Elizabeth, Kwiatkowski, Dominic P., Merson, Laura, Ntoumi, Francine, Price, Ric N., Raman, Jaishree, Roos, David S., ter Kuile, Feiko, Tinto, Halidou, Tomko, Sheena S., White, Nicholas J., Barnes, Karen I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Tropical Medicine and Hygiene 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209939/ https://www.ncbi.nlm.nih.gov/pubmed/35413688 http://dx.doi.org/10.4269/ajtmh.22-0148

Ejemplares similares

Artemisinin and multidrug-resistant Plasmodium falciparum – a threat for malaria control and elimination
por: Dhorda, Mehul, et al.
Publicado: (2021)

Optimal sampling designs for accurate estimation of parasite clearance in the context of artemisinin resistance
por: Flegg, Jennifer A, et al.
Publicado: (2012)

Preventing antimalarial drug resistance with triple artemisinin-based combination therapies
por: Nguyen, Tran Dang, et al.
Publicado: (2023)

Deploying triple artemisinin-based combination therapy (TACT) for malaria treatment in Africa: ethical and practical considerations
por: Tindana, Paulina, et al.
Publicado: (2021)

Artemisinin Resistance and Stage Dependency of Parasite Clearance in Falciparum Malaria
por: Intharabut, Benjamas, et al.
Publicado: (2019)

Optimal sampling designs for estimation of Plasmodium falciparum clearance rates in patients treated with artemisinin derivatives
por: Flegg, Jennifer A, et al.
Publicado: (2013)

The origins of malaria artemisinin resistance defined by a genetic and transcriptomic background
por: Zhu, Lei, et al.
Publicado: (2018)

Ethical considerations in deploying triple artemisinin-based combination therapies for malaria: An analysis of stakeholders’ perspectives in Burkina Faso and Nigeria
por: Tindana, Paulina, et al.
Publicado: (2022)

The impact of anti-malarial markets on artemisinin resistance: perspectives from Burkina Faso
por: Guissou, Rosemonde M., et al.
Publicado: (2023)

Artemisinin resistance – modelling the potential human and economic costs
por: Lubell, Yoel, et al.
Publicado: (2014)

First trimester use of artemisinin-based combination therapy and the risk of low birth weight and small for gestational age
por: Augusto, Orvalho, et al.
Publicado: (2020)

A review of the frequencies of Plasmodium falciparum Kelch 13 artemisinin resistance mutations in Africa
por: Ndwiga, Leonard, et al.
Publicado: (2021)

A comprehensive RNA handling and transcriptomics guide for high-throughput processing of Plasmodium blood-stage samples
por: Kucharski, Michal, et al.
Publicado: (2020)

Artemisinin resistance without pfkelch13 mutations in Plasmodium falciparum isolates from Cambodia
por: Mukherjee, Angana, et al.
Publicado: (2017)

Pregnancy outcomes after first-trimester treatment with artemisinin derivatives versus non-artemisinin antimalarials: a systematic review and individual patient data meta-analysis
por: Saito, Makoto, et al.
Publicado: (2023)

Parasite clearance rates in Upper Myanmar indicate a distinctive artemisinin resistance phenotype: a therapeutic efficacy study
por: Tun, Kyaw Myo, et al.
Publicado: (2016)

To what extent are the antimalarial markets in African countries ready for a transition to triple artemisinin-based combination therapies?
por: de Haan, Freek, et al.
Publicado: (2021)

Severe Malaria Not Responsive to Artemisinin Derivatives in Man Returning from Angola to Vietnam
por: Ringwald, Pascal, et al.
Publicado: (2015)

Mapping genetic markers of artemisinin resistance in Plasmodium falciparum malaria in Asia: a systematic review and spatiotemporal analysis
por: Kagoro, Frank M, et al.
Publicado: (2022)

The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study
por: Imwong, Mallika, et al.
Publicado: (2017)

Effectiveness and safety of 3 and 5 day courses of artemether–lumefantrine for the treatment of uncomplicated falciparum malaria in an area of emerging artemisinin resistance in Myanmar
por: Tun, Kyaw Myo, et al.
Publicado: (2018)

Ethical, Regulatory and Market related aspects of Deploying Triple Artemisinin-Based Combination Therapies for Malaria treatment in Africa: A study protocol.
por: Tindana, Paulina, et al.
Publicado: (2021)

Assessment of therapeutic responses to gametocytocidal drugs in Plasmodium falciparum malaria
por: White, Nicholas J, et al.
Publicado: (2014)

An outbreak of artemisinin resistant falciparum malaria in Eastern Thailand
por: Imwong, Mallika, et al.
Publicado: (2015)

Early parasitological response following artemisinin-containing regimens: a critical review of the literature
por: Das, Debashish, et al.
Publicado: (2013)

Impact of Three-Year Intermittent Preventive Treatment Using Artemisinin-Based Combination Therapies on Malaria Morbidity in Malian Schoolchildren
por: Maiga, Hamma, et al.
Publicado: (2020)

Artemisinin resistance in the malaria parasite, Plasmodium falciparum, originates from its initial transcriptional response
por: Zhu, Lei, et al.
Publicado: (2022)

Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Mali: a systematic review and meta-analysis
por: Maiga, Fatoumata O., et al.
Publicado: (2021)

Contribution of Functional Antimalarial Immunity to Measures of Parasite Clearance in Therapeutic Efficacy Studies of Artemisinin Derivatives
por: O’Flaherty, Katherine, et al.
Publicado: (2019)

The power of pooled analysis to inform optimal dosing strategies for Artemisinin Combination Therapies (ACTs)
por: Guerin, Philippe J, et al.
Publicado: (2012)

Laboratory Detection of Artemisinin-Resistant Plasmodium falciparum
por: Chotivanich, Kesinee, et al.
Publicado: (2014)

Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?
por: van der Pluijm, Rob W, et al.
Publicado: (2022)

Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker
por: Tun, Kyaw M, et al.
Publicado: (2015)

Artemisinin-Based Combination Therapy Versus Quinine or Other Combinations for Treatment of Uncomplicated Plasmodium falciparum Malaria in the Second and Third Trimester of Pregnancy: A Systematic Review and Meta-Analysis
por: Burger, Renée J., et al.
Publicado: (2015)

Artemisinin-based combinations versus amodiaquine plus sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Faladje, Mali
por: Kayentao, Kassoum, et al.
Publicado: (2009)

Optimal health and disease management using spatial uncertainty: a geographic characterization of emergent artemisinin-resistant Plasmodium falciparum distributions in Southeast Asia
por: Grist, Eric P. M., et al.
Publicado: (2016)

First-trimester artemisinin derivatives and quinine treatments and the risk of adverse pregnancy outcomes in Africa and Asia: A meta-analysis of observational studies
por: Dellicour, Stephanie, et al.
Publicado: (2017)

Oxidative stress and protein damage responses mediate artemisinin resistance in malaria parasites
por: Rocamora, Frances, et al.
Publicado: (2018)

The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia
por: Maude, Richard J, et al.
Publicado: (2009)

Adverse effects of mefloquine for the treatment of uncomplicated malaria in Thailand: A pooled analysis of 19, 850 individual patients
por: Lee, Sue J., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_5href0bkngkoq8dg0o57h4c8nh